Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue

Journal of Oral Pathology and Medicine

Volumn 44, Issue 8, 2015, Pages 571-577

  Kauppila, Joonas H ^a,b,c   Korvala, Johanna ^a,b   Siirilä, Kristiina ^a   Manni, Marika ^a   Mäkinen, Laura K ^d,e   Hagström, Jaana ^e,f   Atula, Timo ^d,e   Haglund, Caj ^d   Selander, Katri S ^g   Saarnio, Juha ^a,b,c   Karttunen, Tuomo J ^a,b,c   Lehenkari, Petri P ^a,b,c   Salo, Tuula ^a,b,c,f  

^a UNIVERSITY OF OULU   (Finland)

^b MEDICAL RESEARCH CENTER OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g University of Alabama at Birmingham   (United States)

Author keywords

Invasion; Matrix metalloproteinase 13; Migration; Toll like receptor 9; Tongue cancer

Indexed keywords

COLLAGENASE 3; CPG OLIGODEOXYNUCLEOTIDE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 9; CPG-OLIGONUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE; TLR9 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TONGUE CARCINOMA; TUMOR INVASION; BIOSYNTHESIS; CELL MOTION; DRUG EFFECTS; GENETICS; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; NEOPLASM INVASIVENESS; OLIGODEOXYRIBONUCLEOTIDES; PROGNOSIS; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 9; TONGUE NEOPLASMS;

EID: 84940500229     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12272     Document Type: Article

References (42)

1. Fukata M, Abreu MT. Pathogen recognition receptors, cancer and inflammation in the gut. Curr Opin Pharmacol 2009; 9: 680-7.
2. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-76.
3. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006; 117: 979-87; quiz 988.
4. Means TK, Luster AD. Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus. Ann N Y Acad Sci 2005; 1062: 242-51.
5. Droemann D, Albrecht D, Gerdes J, et al. Human lung cancer cells express functionally active Toll-like receptor 9. Respir Res 2005; 6: 1.
6. Ilvesaro JM, Merrell MA, Li L, et al. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion. Mol Cancer Res 2008; 6: 1534-43.
7. Ilvesaro JM, Merrell MA, Swain TM, et al. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate 2007; 67: 774-81.
8. Jukkola-Vuorinen A, Rahko E, Vuopala KS, et al. Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer. J Innate Immun 2008; 1: 59-68.
9. Kauppila JH, Takala H, Selander KS, et al. Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma. Histopathology 2011; 59: 643-9.
10. Ren T, Xu L, Jiao S, et al. TLR9 signaling promotes tumor progression of human lung cancer cell in vivo. Pathol Oncol Res 2009; 15: 623-30.
11. Schmausser B, Andrulis M, Endrich S, et al. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 2005; 295: 179-85.
12. Takala H, Kauppila JH, Soini Y, et al. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression. J Innate Immun 2011; 3: 631-8.
13. Chang YJ, Wu MS, Lin JT, et al. Helicobacter pylori-Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol 2005; 175: 8242-52.
14. Merrell MA, Ilvesaro JM, Lehtonen N, et al. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 2006; 4: 437-47.
15. Ren T, Wen ZK, Liu ZM, et al. Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis. Cancer Biol Ther 2007; 6: 1704-9.
16. Kauppila JH, Karttunen TJ, Saarnio J, et al. Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion. APMIS 2013; 121: 511-22.
17. Gillison ML. Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck 2007; 29: 779-92.
18. Moller H. Changing incidence of cancer of the tongue, oral cavity, and pharynx in Denmark. J Oral Pathol Med 1989; 18: 224-9.
19. Rosenquist K, Wennerberg J, Schildt EB, et al. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 2005; 125: 1327-36.
20. Bello IO, Vered M, Dayan D, et al. Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol 2011; 47: 33-8.
21. Bonnardot L, Bardet E, Steichen O, et al. Prognostic factors for T1-T2 squamous cell carcinomas of the mobile tongue: a retrospective cohort study. Head Neck 2011; 33: 928-34.
22. Kim KY, Li S, Cha JD, et al. Significance of molecular markers in survival prediction of oral squamous cell carcinoma. Head Neck 2012; 34: 929-36.
23. Kauppila JH, Mattila AE, Karttunen TJ, et al. Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue. Br J Cancer 2013; 108: 638-43.
24. Siponen M, Kauppila JH, Soini Y, et al. TLR4 and TLR9 are induced in oral lichen planus. J Oral Pathol Med 2012; 41: 741-7.
25. Min R, Zun Z, Siyi L, et al. Increased expression of Toll-like receptor-9 has close relation with tumour cell proliferation in oral squamous cell carcinoma. Arch Oral Biol 2011; 56: 877-84.
26. Ruan M, Zhang Z, Li S, et al. Activation of toll-like receptor-9 promotes cellular migration via up-regulating MMP-2 expression in oral squamous cell carcinoma. PLoS One 2014; 9: e92748.
27. Tuomela J, Sandholm J, Karihtala P, et al. Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer. Breast Cancer Res Treat 2012; 135: 481-93.
28. Nurmenniemi S, Sinikumpu T, Alahuhta I, et al. A novel organotypic model mimics the tumor microenvironment. Am J Pathol 2009; 175: 1281-91.
29. Makinen LK, Hayry V, Atula T, et al. Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer. J Oral Pathol Med 2012; 41: 394-9.
30. Hadler-Olsen E, Kanapathippillai P, Berg E, et al. Gelatin in situ zymography on fixed, paraffin-embedded tissue: zinc and ethanol fixation preserve enzyme activity. J Histochem Cytochem 2010; 58: 29-39.
31. Hemmi H, Takeuchi O, Kawai T, et al. A toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-5.
32. Meng Y, Kujas M, Marie Y, et al. Expression of TLR9 within human glioblastoma. J Neurooncol 2008; 88: 19-25.
33. Korvala J, Harjula T, Siirila K, et al. Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis. J Oral Pathol Med 2014; 43: 530-7.
34. Meurman JH. Oral microbiota and cancer. J Oral Microbiol 2010; 2.
35. Mager DL, Haffajee AD, Devlin PM, et al. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 2005; 3: 27.
36. Oblak A, Jerala R. Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol 2011; 2011: 609579.
37. Yang HZ, Cui B, Liu HZ, et al. Blocking TLR2 activity attenuates pulmonary metastases of tumor. PLoS One 2009; 4: e6520.
38. Kauppila JH, Mattila AE, Karttunen TJ, et al. Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis. Oncoimmunology 2013; 2: e23620.
39. Akira S, Takeda K. Functions of toll-like receptors: lessons from KO mice. C R Biol 2004; 327: 581-9.
40. Lande R, Gregorio J, Facchinetti V, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449: 564-9.
41. Tuomela J, Sandholm J, Kaakinen M, et al. DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells. Breast Cancer Res Treat 2013; 142: 477-87.
42. Bitu CC, Kauppila JH, Bufalino A, et al. Cathepsin K is present in invasive oral tongue squamous cell carcinoma in vivo and in vitro. PLoS One 2013; 8: e70925.